EVMN - Latest News

Evommune, Inc. (EVMN), operates in Healthcare / Biotechnology, trades on NYSE.

Market capitalization stands near $356.7M. Beta to the broader market is 0.10.

The article list below shows the most recent EVMN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent EVMN Headlines

Evommune, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Evommune, Inc. (EVMN)

prnewswire.com - Jun 30, 2026

Evommune's CEO and CSO sold shares on June 22, 2026, under Rule 10b5-1 plans adopted months earlier -- days before the Company disclosed that EVO756 f

EVMN Stock Tanks as Phase IIb Urticaria Study Misses Primary Goal

zacks.com - Jun 30, 2026

Evommune shares fall after its phase IIb CSU study misses the primary endpoint, prompting the company to halt further development of EVO756 for the in

Evommune's Skin Disorder Study Falls Short

benzinga.com - Jun 29, 2026

Read Also: Evommune Stock Cools Off After Big Rally On Successful Eczema Trial

Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Chronic Spontaneous Urticaria

businesswire.com - Jun 29, 2026

PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc.

Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights

businesswire.com - May 7, 2026

PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc.

How News Affects EVMN Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track EVMN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked EVMN news questions

What is the latest EVMN news headline?

The most recent EVMN headline (Jun 30, 2026) is "Evommune, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Evommune, Inc. (EVMN)". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the EVMN news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What EVMN news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual EVMN options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.